This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Vascular Ulcer Treatment Market

Explore Key Trends with FMI: Lifestyle Changes and Increasing Awareness Impact the Global Sector

Vascular Ulcer Treatment Market By Type, Treatment, Distribution Channel & Region - Forecast 2022-2032

Vascular Ulcer Treatment Market Outlook (2022-2032)

[306 Pages Report] The global vascular ulcer treatment demand is expected to rise at a CAGR of 4.7%. The market revenue is likely to be valued at US$ 2,638.6 million in 2022, and exhibit a revenue growth of US$ 4,380 million by 2032.

Rising cases of obesity, coupled with changing lifestyles of people, are increasing the rates of chronic illnesses, such as diabetes and vascular disease. These factors are anticipated to accelerate the vascular ulcer treatment market.

However, lack of awareness on the benefits of the treatment and lack of skilled healthcare professionals serve as major challenges for the market.

On the other hand, demand for compression hosiery products is expected to spur due to the high rates of recurrence after healing. This poses revenue opportunities for the vascular ulcer treatment market share.

Attributes

Details

Vascular Ulcer Treatment Market Size (2022)

US$2,638.6 Mn

Vascular Ulcer Treatment Market Size (2032)

US$ 4,380 Mn

Vascular Ulcer Treatment Market CAGR

4.7%

Multi-component and two-layer compression therapy systems replacing traditional treatment options have provided clinicians the ease of bandage applications and products that deliver effective therapeutic compression. This is expected to significantly accelerate the market growth.

The preference of home care settings for the majority of the geriatric population to treat ulcers is likely to expand the market size. In addition to this, initiatives to improve the knowledge and competence about ulcer treatments for nursing staff by reliable social care service organizations may be beneficial.

Trained staff offering personalized wound care products, along with the increasing number of specialty clinics with advanced facilities, is likely to expand the market at a considerable growth. The rise in the hospitalization rate and increasing healthcare infrastructure is anticipated to surge the demand for vascular ulcer treatment.

Inflammation and pain in patients are attempted to be reduced by electrical stimulation and electroceuticals, which improves clinical numbers. This is further expected to accelerate the market trends.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Key Attributes that Drive the Vascular Ulcer Treatment Market?

Increasing prevalence of hypertension and peripheral vascular treatment disease are expected to surge the demand for vascular ulcer treatment. Moreover, rising awareness about innovative dressings and bio skin treatments to provide relief to patients is likely to expand the market size.

Rising geriatric population, and the knees and hip replacement surgery implemented following previous leg surgeries, are expected to boost market growth. Furthermore, mergers and acquisitions among market players contribute to the vascular ulcer treatment market.

Combining different modalities for a more efficient ulcer treatment, increasing in popularity presents a major driver for the market. Likewise, the availability of different skin substitutes and technologically advanced wound care products further surges the demand.

Growing number of product launches and approvals through government initiatives are expected to increase the vascular ulcer treatment market. Research and development (R&D) activities to initiate new strategies and innovations may positively impact the market.

What are the Drawbacks of Vascular Ulcer Treatment?

The vascular ulcer treatment market share is likely to obstruct due to the high costs of the products associated with the treatments. Moreover, the risk of developing new ulcers in different areas of the body can be the result of prolonged surgical care, which is expected to hamper the vascular ulcer treatment market size.

Lack of awareness about treatment options, as well as limited availability of healthcare professionals in under-developed nations, is anticipated to hinder the market growth. Furthermore, visa cancellations during the pandemic, causing a hiatus for the medical tourism sector, negatively impacted the market share.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Possibilities That Expand the Vascular Ulcer Treatment Market?

New Launches:

Introduction of stockings for the testament of vascular leg ulcers and advanced compression is likely to expand the compression therapy segment. Adoption of these products and services is expected to present lucrative opportunities for the vascular ulcer treatment market.

Health Programs:

The therapeutic effects of compression hosiery products following the vascular ulcer treatment are encouraging grace professionals to introduce health programs. This, along with dressings experiencing a dramatic surge in bulk orders, are likely to boost market growth.

Clinical Evidence:

High availability of published clinical evidence concerning negative pressure wound therapy products is estimated to increase the market share. The growth of the vascular ulcer treatment market is attributed to the increasing number of clinical trials.

What are the Regional Insights of the Vascular Ulcer Treatment Market?

What is the Growth Outlook for the North American Vascular Ulcer Treatment Market?

North America holds the dominant vascular ulcer treatment market share, with a revenue of 37.1%. This is owing to the public initiatives related to diabetes and its rising cases.

Launching innovative products by key market participants significantly contributes to the global market growth. Research and development (R&D) activities on technologically advanced products to improve the treatment of these diseases is expected to positively impact the market.

How is the Europe Vascular Ulcer Treatment Market Growing?

With a revenue of 29.1%, Europe is the second leading vascular ulcer treatment market. This is owing to the rapidly growing geriatric population and high medical insurer reimbursement rates in this region.

Technological developments and the growing trend to combine different modalities for more systematic ulcer treatments. Moreover, the increase in demand for active wound care products is attributed to the rising prevalence of chronic and acute wounds, especially in the U.K.

How is the Performance of the Asia-Pacific Vascular Ulcer Treatment Market?

The Asia-Pacific is expected to witness significant market growth owing to approvals and product launches. Government initiatives further expand the market size. The geriatric population increasing in number, along with the rise in healthcare infrastructure in various countries of this region, is likely to expand the market size.

In addition to this, increasing prevalence of diabetes, as well as a significant growth in the disposable income of the middle class population, further boosts the global demand for the treatment.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Key Companies & Start-Ups Revolutionizing the Vascular Ulcer Treatment Market Space

The expansion of the vascular ulcer treatment market size is owing to the substantial growth during the forecast period, with the prevalence of chronic skin ulcers and diabetes. Hence, start-up companies have taken a keen interest in developing alternative solutions for ulcer treatments through new innovations and strategies.

Venari Medical – They are developers of the medical device for chronic venous disease treatment. The company offers its flagship product BioVena for treating varicose veins and venous ulcers.

ElastiMed – They are developing a wearable compression device to improve blood circulation in the lower extremity by mimicking rhythmic calf muscle contractions and stimulating blood flow.

DeVoro Medical – They are a developer of medical devices for the treatment of cardiac diseases. It has developed smart products focused on peripheral thrombectomy space with a novel flow restoration technology.

These are a few of the many start-up companies coming up with various strategies for ulcer treatments, such as peripheral thrombectomy space with a novel flow restoration technology, wearable compression devices, etc.

On the other hand, key market players strive to remain at the top with innovative plans through collaborations, and extensive research and development activities. Rising cases of chronic ulcers provide lucrative options for market players to devise strategies for the improvement and adoption of vascular ulcer treatments.

KEY MARKET PLAYERS OF THE VASCULAR ULCER TREATMENT MARKET

  • Angio Dynamics

A leading provider of minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease, and oncology. The global company has over 1200 employees and currently reaches more than 50 markets via direct sales and distributors.

  • Sigvaris Group

They offer high quality and innovative offerings in medical compression therapy. Their portfolio caters to a wide range of different needs and indications. They are a reliable partner for their customers around the world, that includes pharmacies, DMEs, orthopedic and medical specialist stores, as well as medical professionals and hospitals.

  • Medtronic

They are significantly growing in biomedical engineering, where they display maximum strength and ability. They provide ground-breaking healthcare technology solutions for the most complex and challenging conditions.

  • 3M

They have a dedication to produce products that provide genuine solutions to real world problems, or products that simply speed up processes to make tasks and surgeries easier. From personal protective equipment to adhesives and insulation-displacement connectors.

OTHER MARKET PARTICIPANTS OF THE VASCULAR ULCER TREATMENT MARKET

  • Angiodynamics
  • Sigvaris Global
  • Medi GmbH & Co. KG
  • Activa Healthcare
  • 3M
  • Medtronic
  • B. Braun Melsungen AG
  • Bristol Myers Squibb Co
  • Sanofi
  • Bayer AG
  • Pfizer Inc
  • Novo Nordisk A/S
  • Cadila Pharmaceuticals Ltd.
  • Cardinal Health
  • Paul Hartmann AG
  • Coloplast Corporation
  • KCI Licensing Inc.
  • Smith & Nephew plc
  • Integra LifeSciences Corporation
  • Mölnlycke Health Care AB

Some of the recent developments in the vascular ulcer treatment market are

  • In October 2019, PolarityTE Inc. announced findings from an open-label, single-arm pilot study, which examined the impact of SkinTE, a novel human cellular and tissue-based product derived from a patient’s own skin, in closing leg ulcers following failure of conventional treatments.
  • In October 2019, 3M completed the acquisition of Acelity Inc. and its KCI subsidiaries worldwide with an aim to expand its product offerings in advanced and surgical wound care.
  • In June 2019, Milliken & Company acquired Andover Healthcare, aiming to provide innovative and comprehensive solutions for patient care.
  • In February 2019, AxioBiosolutions launched MaxioCel, the next generation chitosan-based advanced wound care dressing for the treatment of chronic wounds, such as diabetic foot ulcer, venous leg ulcers, and other complex wounds.

Report Scope

Report Attribute

Details

Growth Rate

CAGR of 4.7% from 2022 to 2032

Base year for estimation

2021

Historical data

2016 – 2021

Forecast period

2022 – 2032

Quantitative units

Revenue in USD million and CAGR from 2022 to 2032

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis

Segments covered

  • Type
  • Treatment
  • Distribution Channel
  • Region

Regional scope

  • North America
  • Western Europe
  • Eastern Europe
  • Middle East
  • Africa
  • ASEAN
  • South Asia
  • Rest of Asia
  • Australia
  • New Zealand

Country scope

  • U.S
  • Canada
  • Brazil
  • Argentina
  • Germany
  • The U.K
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • GCC
  • South Africa

Key companies profiled

  • Angiodynamics
  • Sigvaris Global
  • Medi GmbH & Co. KG
  • Activa Healthcare
  • 3M
  • Medtronic
  • B. Braun Melsungen AG
  • Bristol Myers Squibb Co
  • Sanofi
  • Bayer AG
  • Pfizer Inc
  • Novo Nordisk A/S
  • Cadila Pharmaceuticals Ltd.
  • Cardinal Health
  • Paul Hartmann AG
  • Coloplast Corporation
  • KCI Licensing Inc.
  • Smith & Nephew plc
  • Integra LifeSciences Corporation
  • Mölnlycke Health Care AB

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Key Segments Profiled in the Vascular Ulcer Treatment Market Survey

By Type:

  • Arterial Ulcers
  • Neurotrophic Ulcers
  • Venous Ulcers
  • Diabetic Ulcers

By Treatment:

  • Compression
  • Gradual Compression
  • Intermittent Pneumatic Compression
  • Drugs
  • Antibiotics
  • Pentoxifylline
  • Topical Steroids
  • Aspirin
  • Dressings
  • Surgical Therapy
  • Skin Grafting

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies & E-Commerce
  • Drugstores

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe

Frequently Asked Questions

The vascular ulcer treatment market is likely to accumulate a CAGR of 4.7% during the forecast period.

North America is the leading vascular ulcer treatment market.

By 2032, the market is likely to grow to a valuation of US$ 4,380 million.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Disease Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Disease Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Disease Type, 2022-2032

        5.3.1. Arterial Ulcers

        5.3.2. Neurotropic Ulcers

        5.3.3. Venous Ulcers

        5.3.4. Diabetic Ulcers

        5.3.5. Other Disease Types

    5.4. Y-o-Y Growth Trend Analysis By Disease Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Disease Type, 2022-2032

6. Global Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Treatment Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Treatment Type, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment Type, 2022-2032

        6.3.1. Compression

            6.3.1.1. Gradual Compression

            6.3.1.2. Intermittent Pneumatic Compression

        6.3.2. Drugs

            6.3.2.1. Antibiotics

            6.3.2.2. Pentoxifylline

            6.3.2.3. Topical Steroids

            6.3.2.4. Aspirin

        6.3.3. Dressings

        6.3.4. Surgical Therapy

        6.3.5. Skin Grafting

        6.3.6. Other Treatment Types

    6.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Treatment Type, 2022-2032

7. Global Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Distribution Channel

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2022-2032

        7.3.1. Hospital Pharmacies

        7.3.2. Retail Pharmacies

        7.3.3. Online Pharmacies and E-commerce

        7.3.4. Drugstores

        7.3.5. Other Channels

    7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017-2021

    7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022-2032

8. Global Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. Asia Pacific

        8.3.5. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Disease Type

        9.2.3. By Treatment Type

        9.2.4. By Distribution Channel

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Disease Type

        9.3.3. By Treatment Type

        9.3.4. By Distribution Channel

    9.4. Key Takeaways

10. Latin America Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Disease Type

        10.2.3. By Treatment Type

        10.2.4. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Disease Type

        10.3.3. By Treatment Type

        10.3.4. By Distribution Channel

    10.4. Key Takeaways

11. Europe Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Disease Type

        11.2.3. By Treatment Type

        11.2.4. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Disease Type

        11.3.3. By Treatment Type

        11.3.4. By Distribution Channel

    11.4. Key Takeaways

12. Asia Pacific Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. Japan

            12.2.1.3. South Korea

            12.2.1.4. India

            12.2.1.5. Malaysia

            12.2.1.6. Singapore

            12.2.1.7. Australia

            12.2.1.8. New Zealand

            12.2.1.9. Rest of APAC

        12.2.2. By Disease Type

        12.2.3. By Treatment Type

        12.2.4. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Disease Type

        12.3.3. By Treatment Type

        12.3.4. By Distribution Channel

    12.4. Key Takeaways

13. MEA Vascular Ulcer Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. GCC Countries

            13.2.1.2. South Africa

            13.2.1.3. Israel

            13.2.1.4. Rest of MEA

        13.2.2. By Disease Type

        13.2.3. By Treatment Type

        13.2.4. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Disease Type

        13.3.3. By Treatment Type

        13.3.4. By Distribution Channel

    13.4. Key Takeaways

14. Key Countries Vascular Ulcer Treatment Market Analysis

    14.1. U.S.

        14.1.1. Pricing Analysis

        14.1.2. Market Share Analysis, 2021

            14.1.2.1. By Disease Type

            14.1.2.2. By Treatment Type

            14.1.2.3. By Distribution Channel

    14.2. Canada

        14.2.1. Pricing Analysis

        14.2.2. Market Share Analysis, 2021

            14.2.2.1. By Disease Type

            14.2.2.2. By Treatment Type

            14.2.2.3. By Distribution Channel

    14.3. Brazil

        14.3.1. Pricing Analysis

        14.3.2. Market Share Analysis, 2021

            14.3.2.1. By Disease Type

            14.3.2.2. By Treatment Type

            14.3.2.3. By Distribution Channel

    14.4. Mexico

        14.4.1. Pricing Analysis

        14.4.2. Market Share Analysis, 2021

            14.4.2.1. By Disease Type

            14.4.2.2. By Treatment Type

            14.4.2.3. By Distribution Channel

    14.5. Germany

        14.5.1. Pricing Analysis

        14.5.2. Market Share Analysis, 2021

            14.5.2.1. By Disease Type

            14.5.2.2. By Treatment Type

            14.5.2.3. By Distribution Channel

    14.6. U.K.

        14.6.1. Pricing Analysis

        14.6.2. Market Share Analysis, 2021

            14.6.2.1. By Disease Type

            14.6.2.2. By Treatment Type

            14.6.2.3. By Distribution Channel

    14.7. France

        14.7.1. Pricing Analysis

        14.7.2. Market Share Analysis, 2021

            14.7.2.1. By Disease Type

            14.7.2.2. By Treatment Type

            14.7.2.3. By Distribution Channel

    14.8. Spain

        14.8.1. Pricing Analysis

        14.8.2. Market Share Analysis, 2021

            14.8.2.1. By Disease Type

            14.8.2.2. By Treatment Type

            14.8.2.3. By Distribution Channel

    14.9. Italy

        14.9.1. Pricing Analysis

        14.9.2. Market Share Analysis, 2021

            14.9.2.1. By Disease Type

            14.9.2.2. By Treatment Type

            14.9.2.3. By Distribution Channel

    14.10. China

        14.10.1. Pricing Analysis

        14.10.2. Market Share Analysis, 2021

            14.10.2.1. By Disease Type

            14.10.2.2. By Treatment Type

            14.10.2.3. By Distribution Channel

    14.11. Japan

        14.11.1. Pricing Analysis

        14.11.2. Market Share Analysis, 2021

            14.11.2.1. By Disease Type

            14.11.2.2. By Treatment Type

            14.11.2.3. By Distribution Channel

    14.12. South Korea

        14.12.1. Pricing Analysis

        14.12.2. Market Share Analysis, 2021

            14.12.2.1. By Disease Type

            14.12.2.2. By Treatment Type

            14.12.2.3. By Distribution Channel

    14.13. Malaysia

        14.13.1. Pricing Analysis

        14.13.2. Market Share Analysis, 2021

            14.13.2.1. By Disease Type

            14.13.2.2. By Treatment Type

            14.13.2.3. By Distribution Channel

    14.14. Singapore

        14.14.1. Pricing Analysis

        14.14.2. Market Share Analysis, 2021

            14.14.2.1. By Disease Type

            14.14.2.2. By Treatment Type

            14.14.2.3. By Distribution Channel

    14.15. Australia

        14.15.1. Pricing Analysis

        14.15.2. Market Share Analysis, 2021

            14.15.2.1. By Disease Type

            14.15.2.2. By Treatment Type

            14.15.2.3. By Distribution Channel

    14.16. New Zealand

        14.16.1. Pricing Analysis

        14.16.2. Market Share Analysis, 2021

            14.16.2.1. By Disease Type

            14.16.2.2. By Treatment Type

            14.16.2.3. By Distribution Channel

    14.17. GCC Countries

        14.17.1. Pricing Analysis

        14.17.2. Market Share Analysis, 2021

            14.17.2.1. By Disease Type

            14.17.2.2. By Treatment Type

            14.17.2.3. By Distribution Channel

    14.18. South Africa

        14.18.1. Pricing Analysis

        14.18.2. Market Share Analysis, 2021

            14.18.2.1. By Disease Type

            14.18.2.2. By Treatment Type

            14.18.2.3. By Distribution Channel

    14.19. Israel

        14.19.1. Pricing Analysis

        14.19.2. Market Share Analysis, 2021

            14.19.2.1. By Disease Type

            14.19.2.2. By Treatment Type

            14.19.2.3. By Distribution Channel

15. Market Structure Analysis

    15.1. Competition Dashboard

    15.2. Competition Benchmarking

    15.3. Market Share Analysis of Top Players

        15.3.1. By Regional

        15.3.2. By Disease Type

        15.3.3. By Treatment Type

        15.3.4. By Distribution Channel

16. Competition Analysis

    16.1. Competition Deep Dive

        16.1.1. Angiodynamics

            16.1.1.1. Overview

            16.1.1.2. Product Portfolio

            16.1.1.3. Profitability by Market Segments

            16.1.1.4. Sales Footprint

            16.1.1.5. Strategy Overview

                16.1.1.5.1. Marketing Strategy

        16.1.2. Sigvaris Global

            16.1.2.1. Overview

            16.1.2.2. Product Portfolio

            16.1.2.3. Profitability by Market Segments

            16.1.2.4. Sales Footprint

            16.1.2.5. Strategy Overview

                16.1.2.5.1. Marketing Strategy

        16.1.3. Medi GmbH & Co. KG

            16.1.3.1. Overview

            16.1.3.2. Product Portfolio

            16.1.3.3. Profitability by Market Segments

            16.1.3.4. Sales Footprint

            16.1.3.5. Strategy Overview

                16.1.3.5.1. Marketing Strategy

        16.1.4. Activa Healthcare

            16.1.4.1. Overview

            16.1.4.2. Product Portfolio

            16.1.4.3. Profitability by Market Segments

            16.1.4.4. Sales Footprint

            16.1.4.5. Strategy Overview

                16.1.4.5.1. Marketing Strategy

        16.1.5. 3M

            16.1.5.1. Overview

            16.1.5.2. Product Portfolio

            16.1.5.3. Profitability by Market Segments

            16.1.5.4. Sales Footprint

            16.1.5.5. Strategy Overview

                16.1.5.5.1. Marketing Strategy

        16.1.6. Medtronic

            16.1.6.1. Overview

            16.1.6.2. Product Portfolio

            16.1.6.3. Profitability by Market Segments

            16.1.6.4. Sales Footprint

            16.1.6.5. Strategy Overview

                16.1.6.5.1. Marketing Strategy

        16.1.7. B. Braun

            16.1.7.1. Overview

            16.1.7.2. Product Portfolio

            16.1.7.3. Profitability by Market Segments

            16.1.7.4. Sales Footprint

            16.1.7.5. Strategy Overview

                16.1.7.5.1. Marketing Strategy

        16.1.8. L&R Medical

            16.1.8.1. Overview

            16.1.8.2. Product Portfolio

            16.1.8.3. Profitability by Market Segments

            16.1.8.4. Sales Footprint

            16.1.8.5. Strategy Overview

                16.1.8.5.1. Marketing Strategy

        16.1.9. Sanofi

            16.1.9.1. Overview

            16.1.9.2. Product Portfolio

            16.1.9.3. Profitability by Market Segments

            16.1.9.4. Sales Footprint

            16.1.9.5. Strategy Overview

                16.1.9.5.1. Marketing Strategy

        16.1.10. Bayer

            16.1.10.1. Overview

            16.1.10.2. Product Portfolio

            16.1.10.3. Profitability by Market Segments

            16.1.10.4. Sales Footprint

            16.1.10.5. Strategy Overview

                16.1.10.5.1. Marketing Strategy

        16.1.11. Pfizer

            16.1.11.1. Overview

            16.1.11.2. Product Portfolio

            16.1.11.3. Profitability by Market Segments

            16.1.11.4. Sales Footprint

            16.1.11.5. Strategy Overview

                16.1.11.5.1. Marketing Strategy

        16.1.12. Cadila Pharmaceuticals Ltd.

            16.1.12.1. Overview

            16.1.12.2. Product Portfolio

            16.1.12.3. Profitability by Market Segments

            16.1.12.4. Sales Footprint

            16.1.12.5. Strategy Overview

                16.1.12.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Disease Type, 2017-2032

Table 3: Global Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 4: Global Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 5: North America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Disease Type, 2017-2032

Table 7: North America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 8: North America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 9: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Disease Type, 2017-2032

Table 11: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 12: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 13: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Disease Type, 2017-2032

Table 15: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 16: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 17: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Disease Type, 2017-2032

Table 19: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 20: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Table 21: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Disease Type, 2017-2032

Table 23: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Treatment Type, 2017-2032

Table 24: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Forecast by Distribution Channel, 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Vascular Ulcer Treatment Market Value (US$ Mn) by Disease Type, 2022-2032

Figure 2: Global Vascular Ulcer Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 3: Global Vascular Ulcer Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 4: Global Vascular Ulcer Treatment Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Disease Type, 2017-2032

Figure 9: Global Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Disease Type, 2022-2032

Figure 10: Global Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Disease Type, 2022-2032

Figure 11: Global Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 12: Global Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 13: Global Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 14: Global Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 15: Global Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 16: Global Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 17: Global Vascular Ulcer Treatment Market Attractiveness by Disease Type, 2022-2032

Figure 18: Global Vascular Ulcer Treatment Market Attractiveness by Treatment Type, 2022-2032

Figure 19: Global Vascular Ulcer Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 20: Global Vascular Ulcer Treatment Market Attractiveness by Region, 2022-2032

Figure 21: North America Vascular Ulcer Treatment Market Value (US$ Mn) by Disease Type, 2022-2032

Figure 22: North America Vascular Ulcer Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 23: North America Vascular Ulcer Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 24: North America Vascular Ulcer Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Disease Type, 2017-2032

Figure 29: North America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Disease Type, 2022-2032

Figure 30: North America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Disease Type, 2022-2032

Figure 31: North America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 32: North America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 33: North America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 34: North America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 35: North America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 36: North America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 37: North America Vascular Ulcer Treatment Market Attractiveness by Disease Type, 2022-2032

Figure 38: North America Vascular Ulcer Treatment Market Attractiveness by Treatment Type, 2022-2032

Figure 39: North America Vascular Ulcer Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 40: North America Vascular Ulcer Treatment Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) by Disease Type, 2022-2032

Figure 42: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 43: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 44: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Disease Type, 2017-2032

Figure 49: Latin America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Disease Type, 2022-2032

Figure 50: Latin America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Disease Type, 2022-2032

Figure 51: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 52: Latin America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 53: Latin America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 54: Latin America Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 55: Latin America Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 56: Latin America Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 57: Latin America Vascular Ulcer Treatment Market Attractiveness by Disease Type, 2022-2032

Figure 58: Latin America Vascular Ulcer Treatment Market Attractiveness by Treatment Type, 2022-2032

Figure 59: Latin America Vascular Ulcer Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 60: Latin America Vascular Ulcer Treatment Market Attractiveness by Country, 2022-2032

Figure 61: Europe Vascular Ulcer Treatment Market Value (US$ Mn) by Disease Type, 2022-2032

Figure 62: Europe Vascular Ulcer Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 63: Europe Vascular Ulcer Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 64: Europe Vascular Ulcer Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Disease Type, 2017-2032

Figure 69: Europe Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Disease Type, 2022-2032

Figure 70: Europe Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Disease Type, 2022-2032

Figure 71: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 72: Europe Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 73: Europe Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 74: Europe Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 75: Europe Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 76: Europe Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 77: Europe Vascular Ulcer Treatment Market Attractiveness by Disease Type, 2022-2032

Figure 78: Europe Vascular Ulcer Treatment Market Attractiveness by Treatment Type, 2022-2032

Figure 79: Europe Vascular Ulcer Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 80: Europe Vascular Ulcer Treatment Market Attractiveness by Country, 2022-2032

Figure 81: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) by Disease Type, 2022-2032

Figure 82: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 83: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 84: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 85: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: Asia Pacific Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: Asia Pacific Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Disease Type, 2017-2032

Figure 89: Asia Pacific Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Disease Type, 2022-2032

Figure 90: Asia Pacific Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Disease Type, 2022-2032

Figure 91: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 92: Asia Pacific Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 93: Asia Pacific Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 94: Asia Pacific Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 95: Asia Pacific Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 96: Asia Pacific Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 97: Asia Pacific Vascular Ulcer Treatment Market Attractiveness by Disease Type, 2022-2032

Figure 98: Asia Pacific Vascular Ulcer Treatment Market Attractiveness by Treatment Type, 2022-2032

Figure 99: Asia Pacific Vascular Ulcer Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 100: Asia Pacific Vascular Ulcer Treatment Market Attractiveness by Country, 2022-2032

Figure 101: MEA Vascular Ulcer Treatment Market Value (US$ Mn) by Disease Type, 2022-2032

Figure 102: MEA Vascular Ulcer Treatment Market Value (US$ Mn) by Treatment Type, 2022-2032

Figure 103: MEA Vascular Ulcer Treatment Market Value (US$ Mn) by Distribution Channel, 2022-2032

Figure 104: MEA Vascular Ulcer Treatment Market Value (US$ Mn) by Country, 2022-2032

Figure 105: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: MEA Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: MEA Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Disease Type, 2017-2032

Figure 109: MEA Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Disease Type, 2022-2032

Figure 110: MEA Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Disease Type, 2022-2032

Figure 111: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Treatment Type, 2017-2032

Figure 112: MEA Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Treatment Type, 2022-2032

Figure 113: MEA Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Treatment Type, 2022-2032

Figure 114: MEA Vascular Ulcer Treatment Market Value (US$ Mn) Analysis by Distribution Channel, 2017-2032

Figure 115: MEA Vascular Ulcer Treatment Market Value Share (%) and BPS Analysis by Distribution Channel, 2022-2032

Figure 116: MEA Vascular Ulcer Treatment Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022-2032

Figure 117: MEA Vascular Ulcer Treatment Market Attractiveness by Disease Type, 2022-2032

Figure 118: MEA Vascular Ulcer Treatment Market Attractiveness by Treatment Type, 2022-2032

Figure 119: MEA Vascular Ulcer Treatment Market Attractiveness by Distribution Channel, 2022-2032

Figure 120: MEA Vascular Ulcer Treatment Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Corneal Ulcer Treatment Market

Published : February 2020

Healthcare

Decubitus Ulcer Treatment Products Market

Published : April 2016

Healthcare

Leukemia Therapeutics Treatment Market

Published : February 2022

Google translate

Vascular Ulcer Treatment Market